-term loans from financial institutes amounted 158.5 million baht. (2) Debt to Equity Ratio The Company has debt to equity ratio as of December 31, 2017 equals to 0.23 compared with 0.32 as at December 31
warrant. The Debts position of the Company will be reduced further by repaying the loans of financial institutions and Bond which will reflect to the debt to equity ratio decreasing significantly by the end
holders in form of Right Offering, at the ratio of 5 current shares to 2 new shares. - Loan from financial institution. 8. Expected Benefits for the company 8.1 Will be in accordance with the company’s
to EBITDA ratio) (2) อัตราสวนความสามารถในการชําระดอกเบี้ย (interest coverage ratio) (3) อัตราสวนความสามารถในการชําระภาระผูกพัน (debt service coverage ratio) (4) อัตราหนี้สินรวมตอสวนของผูถือหุนรวม
at Baht 1,513.69 million and Baht 201.49 million respectively. Debt to Equity ratio as at 30th June 2018 and 31st March 2018 were 0.47 and 0.40 times respectively. Higher ratio was mainly from higher
shareholders at the ratio of 4 existing ordinary shares for 3 newly-issued ordinary shares at Baht 10 per share. The subscription and payment period for the newly-issued ordinary shares is 31 July 2018 – 20
selling Dusit Thani Maldives and strong performance from investment in Epicure Catering Co., Ltd. Company’s financial position was still strong with the D/E ratio of 0.94 times which it was still under the
Financial and Ratio As at 31 December 2018 2017 Liquidity Ratio Current Ratio (Time) 1.4 1.7 Quick Ratio (Time) 4.3 3.5 Collection Period (Day) 24.4 25.6 Stock Turnover Period (Day) 8.2 6.9 Payment Period
debt to equity ratio 0.35 times, shown that its sufficient liquidity and strong financial position. Please be informed accordingly, Yours Sincerely, DOD Biotech Public Company Limited (Miss Suwarin